Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
about
Atypicality of atypical antipsychotics.Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialAtypical Antipsychotic Use in the Treatment of Psychosis in Primary CareIntramuscular Olanzapine - a UK case series of early casesOlanzapine Attenuates Mechanical Allodynia in a Rat Model of Partial Sciatic Nerve Ligation.Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TDNeurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol AdministrationPersistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depressionACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies.A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012
P2860
Q24535908-F90342B4-1975-4FC7-9294-C208915B3F1BQ30428213-23AE80AD-9429-41E7-8F55-1452255D0C5DQ33591977-7C2E2BB4-0DC9-4FD8-804A-9F8A9A1403C0Q33718185-33F4A572-2C69-48C3-BD48-FE222C61F17BQ34480263-2F2786A2-4F81-4DAF-B098-235797FA6859Q35665593-75ACF24D-33D5-485E-9668-993181786C2BQ35749903-EE18AC2B-604A-47D2-9E12-D64D0E25D708Q35847279-6CD54E46-F147-4C16-B493-01394D7E65C8Q35924877-B4C0C014-F5F5-4869-9A3C-463C0D50C8C5Q35987580-2D0C81A0-89DC-4278-AECC-A018CDE6963EQ36755045-98D90383-9C81-4FCA-9D2D-4238797996A3Q36885358-103DDF73-D689-4626-A17E-973F70FB70CEQ37139258-21A7158E-930B-427B-A80F-92DDFA83597CQ41862402-6A7532A5-C505-4B05-877E-08F1BE6261B5Q42375282-0AAB5352-1704-48AA-B946-ACEA0D7560DC
P2860
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
@ast
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
@en
type
label
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
@ast
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
@en
prefLabel
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
@ast
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
@en
P1476
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality
@en
P2093
W M Glazer
P478
61 Suppl 3
P577
2000-01-01T00:00:00Z